Cargando...
TIM‐3 and CEACAM1 do not interact in cis and in trans
TIM‐3 has been considered as a target in cancer immunotherapy. In T cells, inhibitory as well as activating functions have been ascribed to this molecule. Its role may therefore depend on the state of T cells and on the presence of interaction partners capable to perform functional pairing. Carcinoe...
Gardado en:
| Publicado en: | Eur J Immunol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7496933/ https://ncbi.nlm.nih.gov/pubmed/32222966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201948400 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|